"10.1371_journal.pone.0060245","plos one","2013-03-28T00:00:00Z","Viraj Kulkarni; Margherita Rosati; Antonio Valentin; Brunda Ganneru; Ashish K Singh; Jian Yan; Morgane Rolland; Candido Alicea; Rachel Kelly Beach; Gen-Mu Zhang; Sylvie Le Gall; Kate E Broderick; Niranjan Y Sardesai; David Heckerman; Beatriz Mothe; Christian Brander; David B Weiner; James I Mullins; George N Pavlakis; Barbara K Felber","Human Retrovirus Pathogenesis Section, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Departments of Microbiology Medicine and Laboratory Medicine, University of Washington, Seattle, Washington, United States of America; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America; Inovio Pharmaceuticals, Inc., Blue Bell, Pennsylvania, United States of America; Microsoft Research, Redmond, Washington, United States of America; IrsiCaixa AIDS Research Institute-HIVACAT, Autonomous University of Barcelona, Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain","Conceived and designed the experiments: M. Rolland JIM DH BM CB SLG DBW AV GNP BKF. Performed the experiments: VK BG AKS CA RKB GMZ BG JY. Analyzed the data: VK AKS RKB M. Rosati BG AKS AV GNP BKF. Contributed reagents/materials/analysis tools: KEB NYS. Wrote the paper: BKF GNP AV JIM.","KEB and NS are employed by Inovio Pharmaceuticals, Inc. as such receive salary, and bonuses and stock options as compensation. DH is employed by Microsoft Research. GNP and BKF are inventors on US Government-owned patents and patent applications related to DNA vaccines and gene expression optimization that have been licensed to several companies. There are no further patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","03","Viraj Kulkarni","VK",20,TRUE,1,7,4,4,TRUE,TRUE,TRUE,4,"11;14;16;17",TRUE
